ZIMBABWE is among the first countries set to introduce a new HIV preventative drug that will be taken once a month in a move that is likely to expand HIV prevention options for citizens. By Patricia Mashiri The new drug, Islatravir (MK-8591) belongs to a class of drugs called First-in-Class Nucleoside Reverse Transcriptase Translocation Inhibitor (NRTTI) With Multiple Mechanisms of Action. These multiple mechanisms of action contribute to its high potency against HIV-1 and drug-resistant variants, and its high barrier to resistance. Dr Nyaradzo Mgodi, Principal Investigator, University of Zimbabwe’s…
Read MoreTag: Dapirivirine
Dapirivirine Ring Not Substitute For Other HIV Prevention Methods- Dr Mgodi
THE Dapirivirine Vaginal Ring, a new effective HIV prevention tool for women, is not a substitute for existing HIV prevention methods but rather an innovation to expand prevention options for women, Dr Nyaradzo Mgodi an HIV expert and histopathologist has said. By Michael Gwarisa Speaking during a Twitter Question and Answer session that was organized by HealthTimes, Dr Mgodi said women need safe and effective biomedical HIV prevention strategies for use throughout their lives and the Dapirivirine ring presented women with such an opportunity. Studies of other HIV prevention…
Read More